Stoke Therapeutics, Inc.

STOKNASDAQHealthcare● Active

$29.00

$-1.01(-3.37%)

Market Cap$1.8B

P/E Ratio—

52W High$40.22

52W Low$10.635

Avg Volume694K

Open$30.52

Beta1.19

Overview

Stoke Therapeutics, Inc. (STOK) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · STOK · as of Mar 16, 2026

Latest filing snapshot

204

+76+59.38%vs prior year

Stoke Therapeutics, Inc. (STOK) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

204

Change (1Y)

+76

Growth % (1Y)

+59.38%

Revenue / Employee

$904.0K

Net Income / Employee

$-33.8K

Market Cap

$1.8B

STOK Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-16	2025-12-31	204	+76	+59.38%
2025-03-18	2024-12-31	128	+18	+16.36%
2024-03-25	2023-12-31	110	-7	-5.98%
2023-03-06	2022-12-31	117	+15	+14.71%
2022-03-10	2021-12-31	102	+23	+29.11%
2021-03-09	2020-12-31	79	+23	+41.07%
2020-03-23	2019-12-31	56	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BioCryst Pharmaceuticals, Inc.

580$1.8B #3

NTLA

Intellia Therapeutics, Inc.

Stoke Therapeutics, Inc.YOU

Spyre Therapeutics, Inc.

73$4.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · STOK peer comparison

About STOK employees

STOK Employees · Headcount

Stoke Therapeutics, Inc. (STOK) employee data is sourced from the annual SEC 10-K filing. As of 2025, Stoke Therapeutics, Inc. had 204 full-time employees globally. Full-time employees only. Global consolidated headcount.

Stoke Therapeutics, Inc. employs 204 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $904,020, reflecting the company's operational efficiency.

Stoke Therapeutics, Inc.'s workforce increased by 76 (59.38%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Stoke Therapeutics, Inc.'s revenue per employee of $904,020 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

STOK Employees · 5 questions

As of the latest SEC 10-K filing (2025), Stoke Therapeutics, Inc. had 204 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Stoke Therapeutics, Inc. employee counthow many employees does Stoke Therapeutics, Inc. haveSTOK total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-16